The New England Journal of Medicine Evidence (NEJME) has published research that further establishes and positions Nordic Bioscience’s extracellular matrix…
Bristol-Myers Squibb wants to strengthen its immuno-oncology even further. For this, it is acquiring Cormorant - a Biotech developing immunotherapies in…